Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Determining eligibility for tax loss harvesting with dividend ETFs involves understanding lot identification, wash sale rules, and cost basis calculations.
15,468 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Zeta Global is accelerating its AI-powered strategy, unlocking new growth channels and investor potential. This artic...
Nvidia is a cornerstone of the AI era, and its upcoming earnings can move markets. This guide breaks down what to con...
Sea Limited blends e-commerce, gaming, and fintech in Southeast Asia. This article explores whether its stock is a li...
Stellantis unveiled a bold €60 billion turnaround plan at Investor Day, aiming to reshape costs, cash flow, and a mod...
Parsons Corp faces a tough mix: a record backlog rising margins boost profitability, yet an upcoming policy and contr...
Two NASA contract wins have put Intuitive Machines on investors’ radar, but do they move the needle for long-term ret...
America marks 250 years with a focus on risk-sharing as the true engine of progress. The greatest lesson may be the b...
Imagine Micron topping a trillion-dollar market cap. The market would react in unpredictable ways. This guide explain...
A sudden rise in sweetgreen stock often stirs chatter among traders and fans alike. This article explains the common ...
Bitcoin recently touched a six-week low as volatility remained elevated. This piece explains why bitcoin traders incr...
Stride stock has fallen significantly over the last year. This article digs into the reasons behind the decline and e...